ClinicalTrials.gg
Not yet recruitingNCT07826273Updated Sep 17, 2026

Cardiac Arrhythmias in Pediatric Emergency Department

An observational study in Arrhythmias, Cardiac, Tachycardia, Supraventricular and Bradycardia, sponsored by Assiut University. Not yet recruiting. Open to participants aged 1 Month to 18 Years. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
73
Ages
1 Month to 18 Years
Sex
All
01

Study summary

This cross-sectional study aims to determine the incidence, clinical presentation, and outcome of cardiac arrhythmias among children presenting to the Emergency Department of Assiut University Children Hospital.

Read the detailed description

Cardiac arrhythmias are a significant concern in the pediatric emergency setting. This observational study will include children aged 1 month to 18 years presenting with symptoms suggestive of arrhythmia (palpitation, chest pain, syncope, dyspnea, or respiratory distress).

All participants will undergo full history, clinical examination, 12-lead ECG, and additional investigations as indicated (echocardiography, Holter, laboratory tests). Incidence of different arrhythmia types, clinical picture, and short-term outcomes will be recorded.

02

Conditions studied

  • Arrhythmias, Cardiac
  • Tachycardia, Supraventricular
  • Bradycardia

Keywords

  • Cardiac arrhythmia
  • Pediatric emergency
  • Supraventricular tachycardia
  • ECG
  • Assiut
03

In context

Arrhythmias, Cardiac

1,051 studies on the registry are indexed under Arrhythmias, Cardiac; 236 are open to participants now.

This study's planned enrollment of 73 is below the median of 200 across 467 observational studies indexed under Arrhythmias, Cardiac.

Browse Arrhythmias, Cardiac studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children aged 1 month to 18 years presenting to the Emergency Department of Assiut University Children Hospital with symptoms suggestive of cardiac arrhythmia.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age from 1 month to 18 years
  • Presenting with palpitation, chest pain, syncope, dyspnea, or respiratory distress
  • Written from parents or legal guardians

Exclusion criteria

Exclusion Criteria:

  • Age below 1 month
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
73 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Single cohort: Children presenting to pediatric ED

    Children aged 1 month to 18 years presenting to the Emergency Department with symptoms suggestive of cardiac arrhythmia who will undergo ECG and clinical assessment.

06

What researchers measure

Primary outcomes

  1. Incidence of cardiac arrhythmias

    Proportion of children presenting to the pediatric emergency department who are diagnosed with cardiac arrhythmia based on 12-lead ECG.

    Time frame: Baseline

Secondary outcomes

  1. Types of arrhythmias

    Proportion of specific arrhythmia types (sinus tachycardia, supraventricular tachycardia, ventricular tachycardia, bradyarrhythmias, premature beats, and others) among diagnosed cases.

    Time frame: Baseline

  2. Need for PICU admission

    Proportion of children with cardiac arrhythmia who require admission to the pediatric intensive care unit.

    Time frame: Baseline

  3. Need for cardioversion

    Proportion of children who require electrical or pharmacological cardioversion.

    Time frame: Baseline

  4. Mortality

    Proportion of children with cardiac arrhythmia who die during the emergency department visit or hospital stay.

    Time frame: At 30 days

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Clausen H, Theophilos T, Jackno K, Babl FE. Paediatric arrhythmias in the emergency department. Emerg Med J. 2012 Sep;29(9):732-7. doi: 10.1136/emermed-2011-200242. Epub 2011 Sep 21. PubMed 21946177 ↗
  • Mariani MV, Pierucci N, Fanisio F, Laviola D, Silvetti G, Piro A, La Fazia VM, Chimenti C, Rebecchi M, Drago F, Miraldi F, Natale A, Vizza CD, Lavalle C. Inherited Arrhythmias in the Pediatric Population: An Updated Overview. Medicina (Kaunas). 2024 Jan 3;60(1):94. doi: 10.3390/medicina60010094. PubMed 38256355 ↗
  • Hanash CR, Crosson JE. Emergency diagnosis and management of pediatric arrhythmias. J Emerg Trauma Shock. 2010 Jul;3(3):251-60. doi: 10.4103/0974-2700.66525. PubMed 20930969 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07826273
Lead sponsor
Assiut University
Responsible party
Hossam Hassan Abdel-Kader Hassan (Resident Physician, Assiut University) — Principal investigator
First posted
Sep 17, 2026
Start date
Sep 13, 2026 (estimated)
Primary completion
Sep 13, 2027 (estimated)
Completion
Feb 25, 2028 (estimated)
Last update
Sep 17, 2026

Study contacts

Hossam H Abdel kader, Resident
Contact
Husam.18313179@med.aun.edu.eg
+20 11 22524212
Ghada O Elsedfy, prof
study chair · pediatrics Department, Assiut University Hospitals

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion